1. Home
  2. TOUR vs GANX Comparison

TOUR vs GANX Comparison

Compare TOUR & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tuniu Corporation

TOUR

Tuniu Corporation

N/A

Current Price

$0.67

Market Cap

89.3M

ML Signal

N/A

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$1.85

Market Cap

72.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOUR
GANX
Founded
2006
2017
Country
China
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.3M
72.7M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
TOUR
GANX
Price
$0.67
$1.85
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.50
AVG Volume (30 Days)
120.6K
714.6K
Earning Date
03-05-2026
05-13-2026
Dividend Yield
4.94%
N/A
EPS Growth
N/A
31.46
EPS
N/A
N/A
Revenue
N/A
$55,180.00
Revenue This Year
$9.93
N/A
Revenue Next Year
$10.81
N/A
P/E Ratio
$87.34
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.56
$1.41
52 Week High
$1.01
$4.34

Technical Indicators

Market Signals
Indicator
TOUR
GANX
Relative Strength Index (RSI) 56.31 39.37
Support Level $0.74 $1.60
Resistance Level $0.79 $2.03
Average True Range (ATR) 0.05 0.19
MACD 0.00 -0.03
Stochastic Oscillator 59.08 12.05

Price Performance

Historical Comparison
TOUR
GANX

About TOUR Tuniu Corporation

Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: